EMEA elects chair, vice-chair
This article was originally published in The Tan Sheet
Executive Summary
Konstantin Keller will once again be the chair of the European Medicines Agency's Committee on Herbal Medicinal Products, the agency says Oct. 31. Additionally, Ioanna Chinou is the new vice-chair. Chinou and Keller have three-year mandates with EMEA. Keller currently works in the Department of International Pharmaceutical Affairs at the German Federal Ministry of Health, EMEA says. Chinou is an associate professor of pharmacognosy and chemistry of natural products at the School of Pharmacy, University of Athens, Greece. Chinou is also vice-chair of the HMPC Working Party on Community Monographs and Community List, according to the agency...
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.